Ocugen Inc. buy me8
Start price
09.01.23
/
0%
€1.55
Target price
09.01.24
-
Performance (%)
-27.19%
End price
21.01.23
€1.13
Summary
This prediction ended on 21.01.23 with a price of €1.13. The price of Ocugen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.19%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Ocugen Inc. | 0.604% | 0.604% | 138.785% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
According to me8 what are the pros and cons of Ocugen Inc. for the foreseeable future?
Pros
Stable Large shareholder and/or long term investor
Capable Management
Could be worthwhile Investment >10% per year
Good culture
Cons
Little innovation
Few uniques
Comments by me8 for this prediction
In the thread Ocugen Inc. diskutieren
Buy Ocugen Inc.
In the thread Trading Ocugen Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by me8 for Ocugen Inc.
Ocugen Inc.
Start price
Target price
Perf. (%)
€3.71
22.02.22
22.02.22
€4.00
22.02.23
22.02.23
-38.09%
05.03.22
05.03.22
Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
Ocugen Inc.
Start price
Target price
Perf. (%)
€13.40
03.05.21
03.05.21
€11.00
03.05.22
03.05.22
-19.25%
04.05.21
04.05.21
Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
Ocugen Inc.
Start price
Target price
Perf. (%)
€11.35
08.02.21
08.02.21
€8.00
08.02.22
08.02.22
-30.04%
11.02.21
11.02.21
Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
Ocugen Inc.
Start price
Target price
Perf. (%)
€0.48
27.07.20
27.07.20
-
10.08.20
10.08.20
2.32%
10.08.20
10.08.20
Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques